Skip to main content
Clinical Trials/CTRI/2018/02/012076
CTRI/2018/02/012076
Not yet recruiting
未知

A Prospective Randomized study to compare the efficacy of Propofol-Ketamine combination with Dexmedetomidine for performing Drug Induced Sleep Endoscopy(DISE) in patients of Obstructive Sleep Apnoea.

TATA Motors Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Obstructive Sleep Apnoea
Sponsor
TATA Motors Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
TATA Motors Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients who give their informed consent willingly.
  • Clinical symptoms of snoring, morning headaches,tiredness,daytime sleepiness.
  • ASA status 1\-2\.
  • Apnoea\-Hypopnea Index (AHI) score greater than 5 events per hour on Polysomnography.
  • No active focus of infection in nose and throat.
  • All patients who have previously failed to respond to conservative treatment for OSA, like changes in sleep position and sleep hygiene.
  • Patients who were either intolerant or unwillingly to use continuous positive airway pressure therapy.
  • Patients with no major systemic disease.

Exclusion Criteria

  • Age \< 18 years and \>60 years.
  • Patients with high ASA score \>3\.
  • Severe OSA (AHI \>70 events/hour).
  • Morbid Obesity BMI \>30kg/m2\.
  • Patients with 2nd\-3rd degree A\-V block.
  • Known allergies against the study drugs.
  • Gross maxillary and mandibular deformities (mainly retrognathia) on lateral cephalometry.
  • Patients with psychiatric disorders.
  • Patients who have undergone previous surgical therapies for OSA.
  • Mallampati score of 3\-4\.

Outcomes

Primary Outcomes

Not specified

Similar Trials